Robenidine Analogues Are Potent Antimalarials in Drug-Resistant Plasmodium falciparum

Alina Krollenbrock, Yuexin Li, Jane X. Kelly, Michael K. RiscoeACS 2021 · DOI

Abstract

Robenidine is a veterinary drug used in the poultry industry to treat coccidiosis caused by parasites in the <i>Eimeria</i> genus. Though this compound and related aminoguanidines have recently been studied in other pathogens, the chemotype has not been systematically explored to optimize antimalarial activity despite the close genetic relationship between <i>Eimeria</i> and <i>Plasmodium</i> (both are members of the Apicomplexa phylum of unicellular, spore-forming parasites). In this study, a series of aminoguanidine robenidine analogues was prepared and tested <i>in vitro</i> against <i>Plasmodium falciparum</i>, including multidrug-resistant strains. Selected compounds were further evaluated <i>in vivo</i> against murine <i>Plasmodium yoelii</i> in mice. Iterative structure-activity relationship studies led to the discovery of <b>1</b>, an aminoguanidine with excellent activity against drug-resistant malaria <i>in vitro</i> and impressive <i>in vivo</i> efficacy with an ED<sub>50</sub> value of 0.25 mg/kg/day in a standard 4-day test.
BibTeX
@inproceedings{krollenbrock2021robenidine,
  author = {Alina Krollenbrock and Yuexin Li and Jane X. Kelly and Michael K. Riscoe},
  title = {{Robenidine Analogues Are Potent Antimalarials in Drug-Resistant <i>Plasmodium falciparum</i>}},
  booktitle = {ACS},
  year = {2021},
  doi = {10.1021/acsinfecdis.1c00001},
}

Loading related content...

Figure